14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.53 $2.88 Thursday, 25th Apr 2024 PTN stock ended at $1.72. This is 0.578% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 4.82% from a day low at $1.66 to a day high of $1.74.
90 days $1.47 $5.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Apr 25, 2024 $1.72 $1.74 $1.66 $1.72 75 577
Apr 24, 2024 $1.75 $1.77 $1.72 $1.73 59 251
Apr 23, 2024 $1.72 $1.84 $1.70 $1.75 140 549
Apr 22, 2024 $1.84 $1.86 $1.70 $1.72 206 445
Apr 19, 2024 $1.89 $1.95 $1.84 $1.84 154 533
Apr 18, 2024 $1.89 $1.95 $1.87 $1.89 180 597
Apr 17, 2024 $1.88 $1.94 $1.82 $1.90 232 163
Apr 16, 2024 $1.87 $1.91 $1.81 $1.87 239 597
Apr 15, 2024 $1.94 $1.98 $1.81 $1.82 289 922
Apr 12, 2024 $1.99 $2.03 $1.85 $1.92 319 458
Apr 11, 2024 $1.87 $2.03 $1.87 $2.00 285 935
Apr 10, 2024 $2.11 $2.11 $1.75 $1.87 496 130
Apr 09, 2024 $2.10 $2.17 $1.91 $2.08 816 735
Apr 08, 2024 $1.80 $2.88 $1.80 $2.02 12 640 375
Apr 05, 2024 $1.75 $1.77 $1.69 $1.76 93 753
Apr 04, 2024 $1.72 $1.80 $1.67 $1.74 105 763
Apr 03, 2024 $1.68 $1.72 $1.65 $1.70 97 887
Apr 02, 2024 $1.80 $1.82 $1.68 $1.72 106 120
Apr 01, 2024 $1.86 $1.90 $1.75 $1.76 71 031
Mar 28, 2024 $1.61 $1.92 $1.61 $1.87 395 625
Mar 27, 2024 $1.63 $1.67 $1.58 $1.60 112 751
Mar 26, 2024 $1.55 $1.65 $1.53 $1.62 186 282
Mar 25, 2024 $1.56 $1.60 $1.52 $1.52 96 060
Mar 22, 2024 $1.57 $1.62 $1.51 $1.55 146 166
Mar 21, 2024 $1.58 $1.65 $1.55 $1.62 164 362
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT